- Previous Close
61,900.00 - Open
61,000.00 - Bid 60,000.00 x --
- Ask 60,100.00 x --
- Day's Range
56,100.00 - 61,800.00 - 52 Week Range
31,000.00 - 98,500.00 - Volume
315,471 - Avg. Volume
195,524 - Market Cap (intraday)
641.868B - Beta (5Y Monthly) 1.34
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Nov 14, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 27, 2018
- 1y Target Est
100,166.66
Cosmecca Korea Co., Ltd. engages in the research and development, manufacture, and sale of skincare products in South Korea and internationally. It offers skincare products, including lotion/toner, cream, essence, cleansers, Korean herbal products, mask sheet, scalp care, home scents, body and bath, exfoliators, and treatment products, as well as products for men, babies, and children; functional skincare products, which includes brightening, wrinkle and fine line, UV blocks/sunscreen, tanning, multi-functional, hair and body, and acne care products; and makeup products, such as BB and CC cream, skin cover balms, makeup base, foundation, concealer, lipstick, mascara, eyeliner, eyeshadow, blush/highlighter, and powders. The company was incorporated in 1999 and is headquartered in Eumseong-eup, South Korea.
www.cosmecca.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 241710.KQ
View MorePerformance Overview: 241710.KQ
Trailing total returns as of 11/15/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 241710.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 241710.KQ
View MoreValuation Measures
Market Cap
641.87B
Enterprise Value
707.83B
Trailing P/E
18.63
Forward P/E
13.16
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.26
Price/Book (mrq)
3.29
Enterprise Value/Revenue
1.39
Enterprise Value/EBITDA
8.63
Financial Highlights
Profitability and Income Statement
Profit Margin
6.77%
Return on Assets (ttm)
8.62%
Return on Equity (ttm)
18.61%
Revenue (ttm)
508.49B
Net Income Avi to Common (ttm)
34.45B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
48.14B
Total Debt/Equity (mrq)
41.21%
Levered Free Cash Flow (ttm)
-501.06M